Entrada Therapeutics, Inc. (TRDA) Insider Trading
Sector: Biotechnology · Market Cap: $300M · 0 insider purchases in the last 7 days
No open market insider purchases at Entrada Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track TRDA on your watchlist.
Start for FreeAbout Entrada Therapeutics, Inc. Insider Trading
1 insider at Entrada Therapeutics, Inc. (TRDA) has purchased stock in the past 90 days, totaling $29K across 1 transaction (5,000 shares).
The most recent purchase was by Director Zeiher Bernhardt G on May 20, 2026 — a $29K buy of 5,000 shares at $5.86, bringing their total holdings to 5,000 shares.
Insider buying at TRDA has been lighter than usual — there were 16 purchases in the prior nine months.
TRDA is in the Biotechnology sector within the Biotechnology industry with a market cap of $300M.
Track TRDA insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.